Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Takeuchi

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Histone Deacetylase 3 Inhibition Overcomes <i>BIM</i> Deletion Polymorphism-Mediated Osimertinib Resistance in <i>EGFR-</i>Mutant Lung CancerAzusa Tanimoto, Shinji Takeuchi, Sachiko Arai, et al.
BMC Pulmonary Medicine|December 14, 2018
Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case reportAzusa Tanimoto, Shinji Takeuchi, Hiroshi Kotani, et al.
Cancer Science|August 1, 2020
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinibAkihiro Nishiyama, Shinji Takeuchi, Yuta Adachi, et al.
Molecular Cancer Therapeutics|February 1, 2017
<i>MET</i> Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of <i>EGFR</i>-mutant Lung CancerShigeki Nanjo, Sachiko Arai, Wei Wang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective]Tadaaki Yamada, Koushiro Ohtsubo, Daisuke Ishikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2010
[Combined chemotherapy with cisplatin plus vinorelbine showed efficacy in a case of metastatic primary cutaneous adenoid cystic carcinoma]Tadaaki Yamada, Hisatsugu Mouri, Kouji Izumi, et al.
Cancer Science|June 19, 2021
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancerKoji Fukuda, Sakiko Otani, Shinji Takeuchi, et al.
International Journal of Cancer|January 16, 2013
The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factorTakako Sano, Shinji Takeuchi, Takayuki Nakagawa, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Antiangiogenic therapies for malignant pleural mesotheliomaSeiji Yano, Qi Li, Wei Wang, et al.
International Journal of Cancer|September 18, 2015
Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancerShinji Takeuchi, Koji Fukuda, Sachiko Arai, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Histone Deacetylase 3 Inhibition Overcomes <i>BIM</i> Deletion Polymorphism-Mediated Osimertinib Resistance in <i>EGFR-</i>Mutant Lung CancerAzusa Tanimoto, Shinji Takeuchi, Sachiko Arai, et al.
BMC Pulmonary Medicine|December 14, 2018
Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case reportAzusa Tanimoto, Shinji Takeuchi, Hiroshi Kotani, et al.
Cancer Science|August 1, 2020
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinibAkihiro Nishiyama, Shinji Takeuchi, Yuta Adachi, et al.
Molecular Cancer Therapeutics|February 1, 2017
<i>MET</i> Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of <i>EGFR</i>-mutant Lung CancerShigeki Nanjo, Sachiko Arai, Wei Wang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective]Tadaaki Yamada, Koushiro Ohtsubo, Daisuke Ishikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2010
[Combined chemotherapy with cisplatin plus vinorelbine showed efficacy in a case of metastatic primary cutaneous adenoid cystic carcinoma]Tadaaki Yamada, Hisatsugu Mouri, Kouji Izumi, et al.
Cancer Science|June 19, 2021
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancerKoji Fukuda, Sakiko Otani, Shinji Takeuchi, et al.
International Journal of Cancer|January 16, 2013
The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factorTakako Sano, Shinji Takeuchi, Takayuki Nakagawa, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Antiangiogenic therapies for malignant pleural mesotheliomaSeiji Yano, Qi Li, Wei Wang, et al.
International Journal of Cancer|September 18, 2015
Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancerShinji Takeuchi, Koji Fukuda, Sachiko Arai, et al.
Pageof 12